25.05.2026, 10:38
Kazakhstan approves 32.5 billion tenge biopharmaceutical plant in Alatau SEZ
ALMATY. May 25 (Interfax-Kazakhstan) - The Kazakh government has approved a 32.5 billion tenge investment agreement to build a full-cycle biopharmaceutical complex in the Alatau special economic zone in Almaty region, the prime minister's press service said Monday.
To read the full news articles, Subscribe.
08:33AM
Armenia may face customs duties, gas price changes if Yerevan decides to join EU - Russian deputy PM
May 22, 2026, 06:05PM
Russia ready to share advanced healthcare technologies, methods with CIS partners - PM
May 22, 2026, 06:03PM
Kazakh banks see mortgage demand rebounding in Q2 after 21% drop
May 22, 2026, 05:32PM
VIEWPOINT: Gold price could rise to $5,400-5,600 per ounce in the medium term - PSB
May 22, 2026, 05:30PM
Mazhilis speaker briefs president on constitutional reform legislation
Archive
